Neuromuscular Junction Flashcards

1
Q

Tell me about the ANS and what it regulates?

A
  • Regulates activity of:

Smooth muscles

Exocrine glands (some endocrine glands)

Cardiac tissue

Metabolic activities

  • Involuntary
  • Regulates by brain stem centres
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Tell me about the somatic NS

A
  • Activates skeletal muscle contraction
  • Voluntary body movements
  • Regulated by corticospinal tracts + spinal reflfexes
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Tell me about exocrine and endocrine secretion i.e. what it goes through and to where?

A

exocrine- section into external environment through ducts, e.g. (sweat, oil, wax, enzymes, etc)

endocrine- secretion into internal environment with no ducts and hormones secreted

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Receptors/ agonists present in the sympathetic, parasympathetic and somatic nervous system

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What does the somatic NS not have a relay neuron between?

A

The cell body and muscle receptor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Acetylcholine synthesis and degradation

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Tell me the types of nicotinic receptors?

Where are they located?

A

N1 or NM and N2 or NN

type 1 sits in muscle and type 2 in neuron

Ligand-gated ion channels

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

How many acetylcholine molecules do nicotinic receptors require to bind?

What is the structure of the nicotinic receptors?

A
  • Required binding of two acetylcholine molecules
  • Composed of five subunits (pentamer)
  • Five different types of subunits
  • Alpha, beta, gamma, delta and epsilon
  • 10 different alpha and 4 different beta subunits
  • NM receptors contain only alpha1 and beta1 subtypes plus delta and gamma/epsilon
  • NN receptors contain alpha2-10 and beta2-4 subtypes
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

When was the AA sequence for the nicotinic receptor determined?

A

The amino acid sequence for the nicotinic receptor was determined after solubilization of the receptor from the electric organ of Torpedo californica using anionic detergents such as sodium dodecyl sulfate, passing the receptor through an affinity column containing a bungarotoxin (from snake venom) and washing the receptor from the column. Subsequently, molecular biological techniques were used to clone additional receptor subunits. The nicotinic receptor consists of five polypeptide subunits. The amino acid sequence for the a subunits consists of a glycolipid region (which contains the ACh binding site and a sulfhydryl groups) with four hydrophobic regions that span the membrane. Nine a subunits have been cloned, along with four b subunits. In the neuromuscular junction, d and g subunits also have been identified. The g subunit is replaced by an e subunit in the adult muscle.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

ACh and receptor

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is the neuromuscular junction?

A

a specialised form of synaptic transmission: communication between neurons and skeletal muscle

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Tell me the steps to the major events that occur in NMJ transmission?

A

Major events in NMJ transmission

  1. Motor neuron depolarization causes action potential to travel down the nerve fiber to the neuromuscular junction
  2. Depolarization of the axon terminal causes an influx of Ca2+
  3. which triggers fusion of the synaptic vesicles and release of neurotransmitter (Acetylcholine; ACh) by exocytosis
  4. ACh diffuses across the synaptic cleft and binds to post-synaptic ACh receptor (AChR) located on the muscle fiber at the motor endplate (ligand gated cation channels is the receptor)
  5. Binding of ACh to AChRs opens the channels causing an influx of Na+ (K+ flux out)
  6. depolarization of the sarcolemma that travels down the t-tubules and ultimately causes the release of Ca2+ from the sarcoplasmic reticulum - CONTRACTION.
  7. How Ach is removed: Unbound ACh in synaptic cleft defuses away or is hydrolyzed (inactivated) by acetylcholinesterase (AChE) to acetic acid and choline (choline put back in terminal for the resynthesis of acetylcholine)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Tell me some NMJ disorders?

A
  1. Myasthenia gravis
  2. Lambert-Eaton myasthenic syndrome
  3. Neuromyotonia (Isaac’s syndrome)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Tell me about myasthenia gravis

A
  • “grave muscle weakness”
  • Autoantibodies to the nicotinic AChR on the motor end-plates of muscles.
  • Binding of ACh is blocked and muscle activation is inhibited.
  • The autoantibodies also induce complement-mediated degradation of the AChRs, resulting in progressive weakening of the skeletal muscles.
  • Autoantibodies to MuSK, which is important for the tight clustering of AChRs at the neuromuscular junction .
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Tell me the symptoms to the NMJ disorder myasthenia gravis

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Tell me about the NMJ disorder Lambert-Eaton myasthenic syndrome

A
  • Autoantibodies to presynaptic voltage-gated calcium channel (VGCC)
  • These antibodies interfere with the calcium-dependent release of ACh from the presynaptic membrane and subsequently cause a reduced endplate potential on the postsynaptic membrane, resulting in NMJ transmission failure.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Tell me about the NMJ disorder Neuromyotonia (Isaac’s syndrome)

A
  • Autoantibodies to presynaptic voltage-gated potassium channel (VGKC)
  • Autoimmune neuromyotonia is typically caused by antibodies that bind to potassium channels on the motor nerve resulting in continuous/hyper-excitability.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What is the neurotransmitter always used as the NMJ?

A

Acetylcholine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

A client with myasthenia gravis asks the nurse why the disease has occurred. The nurse bases the reply on the knowledge that there is…?

A

A decreased number of functioning acetylcholine receptor sites

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Katrina a client with myasthenia gravis is to receive immunosuppressive therapy. The nurse understands that this therapy is effective because it…?

A

Decreases the production of autoantibodies that attack the Ach receptors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Drugs working on NMJ

A
22
Q

In the 16th century, what did south americans find out?

What was the active compound for this?

A

In the 16th century, European explorers found that south America natives in the amazon basin were using an arrow poison, curare to produce skeletal muscle paralysis in the animals there were hunting

Active compound- d-tubocurarine

23
Q

NM blocking drugs

A
24
Q

Name 2 toxins that bind with high affinity to nicotinic acetylcholine receptor and cause postsynaptic block at the NMJ

A
  1. Cobratoxin
  2. alpha-bungarotoxin
25
Q

What effects do NMJ blocking agents cause?

A

paralysis - small rapidly moving muscles (eyes, fingers), then limbs, last is respiratory muscles (recovery in reverse order)

26
Q

Name a competitive NMJ blocking agent and how it works

A

Competitive (non-depolarizing) agents e.g. Curare

  • compete with ACh for binding to receptor
  • flaccid, relaxed paralysis
  • non-NMJ effects: ganglia, muscarinic blocking, histamine release
  • NMJ block CAN be reversed by AChE inhibitors
27
Q

Name a non-competitive NMJ blocking agent and how it works?

A

Non-competitive (depolarizing) agents

(suxamethonium/succinylcholine, decamethonium)

  • Phase 1 block:
  • membrane depolarization
  • transient fasciculations followed by paralysis
  • Phase 2 block:
  • Desensitization
  • membrane repolarizes, hyposensitive to ACh
  • NMJ block NOT reversed by AChE inhibitors
28
Q

Tubocurarine is also another competitive NMJ blocking agent. Tell me how this works and at what concentrations certain effects are caused?

A

Tubocurarine, dimethyltubocarine (metacarine)

  • No effect on nerve transmission
  • Muscle can still be stimulated
  • 5-10 mg (iv) produces flaccid paralysis
  • 10-20 mg (iv) can produce apnea, not active orally
  • Can cause histamine release (mast cells)
  • Can block ganglionic receptors [high concentration]
29
Q

Pancuronium is another competitive NMJ blocking agent. Tell me about it?

A

Pancuronium

  • more potent than tubocurarine (x5)
  • reduced histamine release than curare
  • lack of ganglionic blockade
30
Q

Name 3 other NMJ competitive blocking agents

A
  • Gallamine: also, some muscarinic block
  • Mivacurium: short acting, hydrolysis by AChE
  • Atracurium: hydrolysis by AChE
31
Q

Tell me some clinicsl uses of NMJ blocking agents

A
  • Muscle relaxation in surgery
  • Decreases depth of anaesthesia
  • Orthopaedics
  • Dislocation, alignments of fractures
  • Facilitate intubations
  • In mechanical artificial ventilation
  • Facilitate internal examinations
  • Laryngoscopy, bronchoscopy, esophagoscopy
  • Prevent trauma
  • During electroshock therapy
  • Diagnostic
  • Tubocurarine (myasthenia gravis), not commonly used not recommended, edrophonium (tensolin) better
32
Q

NMJ blocking reversing agents

A
33
Q

Acetylcholinesterase inhibitors are naturally occuring in what?

How are they used as weapons?

What can they be used for?

A

Acetylcholinesterase inhibitors

  • Natural: venoms and poisons
  • Weapons: nerve agents, insecticides
  • Drugs:

To treat myasthenia gravis

To treat Alzheimer’s disease

To treat Lewy body dementia

To treat glaucoma

Antidote for anticholinergic poisoning

34
Q

Tell me the following about cholinesterase inhibitors…

  1. What do they increase the availability of?
  2. What do they cause the reverse of?
  3. It is the first line for?
  4. What do they inhibit?
A
  1. Increase the availability of acetylcholine (ACh), partially overcome the decreased receptor availability
  2. Reverse non-depolarizing muscle blockade
  3. First line for ocular myasthenia
  4. They inhibit the acetylcholinesterase enzyme from breaking down Ach, thereby increasing the level and duration of action of neurotransmitter acetylcholine
35
Q

Place this acetylcholinesterase inhibitors in order of increasing duration of action…

Pyridostigmine, Edrophonium, Neostigmine, Distigmine

A

Edrophonium, Neostigmine, Pyridostigmine, Distigmine (in order of increasing duration of action)

36
Q

Tell me about the cholinesterase inhibitor organophosphate?

A

Forms irreversible bonds to the enzyme

37
Q

Over-stimulation of the NMJ leads to a cholinergic crisis and an excess of ACh, what are the symptoms of this?

A

The muscles stop responding to the excess of Ach

  • Vasodilatation of blood vessels
  • Sweating
  • Salivation
  • Bronchial secretions (mucus)
  • Miosis (constriction of eye pupil)
  • Flaccid paralysis
  • Respiratory failure
38
Q

How does nerve gas poisoning come about?

What is the antidote?

A
  • Overstimulation of muscles, organs and glands Symptoms: Ataxia (lack of muscle
  • control), slurred speech, areflexia (loss of reflexes), generalized convulsions, respiratory failure, death
  • ATROPINE IS AN ANTIDOTE!
  • Atropine binds to the acetylcholine receptors and prevents acetylcholine from binding to the receptors
  • Oximes can also be co-administered – regenerate the enzyme
39
Q

The structure of Organophosphate insecticides (parathion)…

What are organophosphates?

A

Organophosphates are irreversible AChE inhibitors

40
Q

How does organophosphate work as an AChE inhibitor?

A

The phosphorous atom covalently binds to a serine hydroxyl group in the active site of acetylcholinesterase (AChE or ACE)

Enzyme no longer functional (inactive)

41
Q

DIFP: diisopropyl fluorophosphate

A
42
Q

Neostigmine is a drug used to treat myasthenia garvis. How does it work?

A
  • AChE inhibitors permit build-up of Ach.
  • More intensive and prolonged activation
  • Action of ACh that is liberated by cholinergic impulses or spontaneous leak from the nerve is enhanced
  • Time prolonged to interact with receptors that are not blocked by auto-antibodies (in Myasthenia Gravis).
43
Q

Tell me the following about Edrophonium…

  • chemical name
  • trade names
  • what it is
  • what it in competition with
  • uses
A
  • N-ethyl-3-hydroxy-N,N-dimethylbenzenaminium
  • Trade names Tensilon, Enlon and Reversol.
  • Edrophonium is a readily reversible AChE inhibitor that prevents breakdown of ACh
  • True competitive inhibition of AChE at the NMJ
  • Rapid dissociation
  • Used in diagnosis myasthenia gravis
  • Tensilon test: differentiate myasthenic crisis from cholinergic crisis
  • myasthenic crisis: not enough neuromuscular stimulation: Edrophonium will reduce the muscle weakness by effectively supplying more ACh
44
Q

The next image is an example of a cholinergic crisis…

A

too much neuromuscular stimulation: Edrophonium will make the muscle weakness worse by inducing a depolarizing block

45
Q

What is physostigmine?

What is it aka?

Clinical uses

A
  • also known as eserine from éséré, Calabar bean: witchcraft
  • Reversible pseudo-competitive AChE inhibitor

Clinical uses

  • Physostigmine is used to treat myasthenia gravis, glaucoma, Alzheimer’s disease and delayed gastic emptying.
  • It can cross the blood brain barrier and can be used to treat effects of atropine and other anticholinergic drug overdoses
46
Q

What is cholinergic hypothesis?

What is it linked to?

A

AChE inhibitors in dementia

Cholinergic hypothesis:

  • Cognitive decline is linked to the loss of cholinergic transmission in hippo and cortex
  • Loss of choline acetyltransferase (CAT) (biochemistry and PET) and loss of cholinergic (presyn.) neurons in forebrain
  • Enhance central cholinergic function
  • Acetylcholine: short half life
  • Muscarinergic agents ineffective and poorly tolerated
  • Nicotinergic agonists vascular side effects
47
Q

Explain some drugs effects over the years and how they helped with dementia?

A
  • Tacrine (1993) centrally active non-competitive reversible AChE inhibitor. 20-30% showed improvement, side effects, 4x/day
  • Donepezil (1997) piperidine-based reversible AChE inhibitor (less ButrylACh), long half-life, side effects
  • Rivastigmine and neostigmine (1998), carbamate AChE inhibitors. Inactivates enzyme for 10h producing a pseudo-irreversible inhibition. Metabolised in liver.
  • Galatamine (snowdrops). Phenonthrene alkaloid. Reversible, competitve AChE inhibitor, that also modulates nicotinic receptors
48
Q

Antispasmodics

A
49
Q

Tell me the symptoms of botulism (food-borne botulism, wound botulism and infant botulism)

A
  • Double vision
  • Blurred vision
  • Droopy eyelids
  • Slurred speech
  • Difficult swallowing
  • Dry mouth
  • Muscle weakness (starts in shoulders and descends through body)
50
Q

Botox uses for both medical and cosmetic reason

A
51
Q

An action potential arriving at the motor endplate causes release of:

A. Acetylcholine which traverses the neuromuscular junction

B. Sodium ions which bind to sodium receptors on the muscle membrane

C. Calcium ions which initiate an action potential along the muscle fibre

D. Noradrenaline which increases muscle metabolic activity

E. None of the above

A